Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
HK:2575
Stock Latest News
Company Announcements
Xuanzhu Biopharmaceutical Sets Board Meeting to Approve 2026 Interim Results
10d ago
2575
Premium
Company Announcements
Xuanzhu Biopharm ordered to pay RMB9.33 million in arbitration over generic drug deal
1M ago
2575
Premium
Company Announcements
Xuanzhu’s Anaprazole Wins NMPA Review Nod for Reflux Esophagitis
2M ago
2575
Premium
Company Announcements
Xuanzhu Biopharma Advances Anaprazole into Phase III Trial for H. pylori Eradication
2M ago
2575
Premium
Company Announcements
Xuanzhu Biopharmaceutical Shareholders Approve AGM Resolutions and Governance Overhaul
2M ago
2575
Premium
Company Announcements
Xuanzhu Biopharmaceutical Adds Employee Representative to Board as Executive Director Resigns
2M ago
2575
Premium
Company Announcements
Xuanzhu Biopharmaceutical updates board and committee roles
2M ago
2575
Premium
Company Announcements
Xuanzhu Biopharmaceutical Sets 2025 AGM With Governance and Capital Mandates on Agenda
3M ago
2575
Premium
Company Announcements
Xuanzhu Biopharmaceutical Overhauls Governance Structure and Board Composition
3M ago
2575
Premium
Company Announcements
Xuanzhu Biopharmaceutical Completes Full H-Share Circulation on HKEX
3M ago
2575
Premium
Company Announcements
Xuanzhu Biopharma Posts Encouraging Early Data for NG-350A in Rectal Cancer
4M ago
2575
Premium
Company Announcements
Xuanzhu’s ALK Inhibitor Dirozalkib Delivers Strong Phase III Results in First-Line Lung Cancer
4M ago
2575
Premium
Company Announcements
Xuanzhu Biopharmaceutical Wins Approval for Major H Share Full Circulation
4M ago
2575
Premium
Company Announcements
Xuanzhu Biopharm Wins Green Light for Phase III Anaprazole Trial in H. pylori
4M ago
2575
Premium
Company Announcements
Xuanzhu Biopharmaceutical Wins CSRC Nod for H Share Full Circulation Plan
4M ago
2575
Premium
Company Announcements
Xuanzhu Biopharm Licenses Key Cancer Drugs to Boston Oncology for MENA Expansion
5M ago
2575
Premium
Company Announcements
Xuanzhu Biopharmaceutical Narrows Annual Loss on Surging Revenue and Deep Cost Cuts
5M ago
2575
Premium
Company Announcements
Xuanzhu’s Breast Cancer Drug Bireociclib Delivers Strong Phase 3 Results Published in JAMA Oncology
5M ago
2575
Premium
Company Announcements
Xuanzhu Biopharm Completes Phase III Patient Enrollment for Anaprazole in Reflux Esophagitis
5M ago
2575
Premium
Company Announcements
Xuanzhu Biopharmaceutical Sets March 30 Board Meeting for 2025 Results and Dividend Decision
5M ago
2575
Premium
Company Announcements
Xuanzhu Biopharm Added to Hong Kong Stock Connect, Boosting Access to Mainland Investors
6M ago
2575
Premium
Company Announcements
Xuanzhu Wins First-Line Breast Cancer Nod for Bireociclib, Extending Market Lead
6M ago
2575
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
